Well-Placed For Growth, But Also Well-Valued For Its Potential: Paratek Pharmaceuticals Inc. (PRTK)
Paratek Pharmaceuticals Inc. (NASDAQ: PRTK) shares are -7.67% down in the year-to-date (YTD) period and have moved up 3.58% or $0.2 higher in the latest